# PeakData

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/peakdata

- Industry: Software
- Headquarters: Zug, Switzerland
- Website: www.peakdata.com
- Total disclosed funding: $12M
- Latest round: Series A (Aug 22, 2022)
- Investors on record: 3

## About

Based in Switzerland, and co-founded in 2018 by Patrick de Boer (CEO), and Michael Feldman, PeakData AG operates as a provider of software based on artificial intelligence that enables pharmaceutical companies to connect with their clients using agile segmentation and targeting. In August 2022, PeakData AG, employing more than 50 employees and has offices in the USA, Germany, UK, Poland, Netherlands, and Switzerland, raised EUR 12.1 million in series A funding led by new investor AlbionVC, with participation from other new investors Heal Capital and Octopus Ventures. 

The business offers a platform powered by artificial intelligence that offers insights and analytics to the top pharmaceutical companies in the world before and after product launches. It also uses big data analytics to gather information from all over the web and build ranked profiles of healthcare professionals. The company works with pharmaceutical firms to improve their scientific and commercial performance by assisting them in enlisting the relevant people and providing them with the appropriate information at the appropriate time. The delivered solutions include impact tracking, expert mapping and profiling, agile segmentation and targeting, and digital activators.

The company intends to use the funds raised in August 2022 to support its expansion objectives and develop its service offerings.

## Funding rounds

- Series A, Aug 22, 2022, $12M — Octopus Investments, AlbionVC, Heal Capital

## Investors

- Octopus Investments (https://capitalatlas.ai/funds/octopus-investments) — Series A
- AlbionVC — Series A
- Heal Capital (https://capitalatlas.ai/funds/heal-capital) — Series A